The forces that govern clonal selection during the genesis and maintenance of specific T cell responses are complex, but amenable to decryption by interrogation of constituent clonotypes within the antigen-experienced T cell pools. Here, we used point-mutated peptide–major histocompatibility complex class I (pMHCI) antigens, unbiased TCRB gene usage analysis, and polychromatic flow cytometry to probe directly ex vivo the clonal architecture of antigen-specific CD8+ T cell populations under conditions of persistent exposure to structurally stable virus-derived epitopes. During chronic infection with cytomegalovirus and Epstein-Barr virus, CD8+ T cell responses to immunodominant viral antigens were oligoclonal, highly skewed, and exhibited diverse clonotypic configurations; TCRB CDR3 sequence analysis indicated positive selection at the protein level. Dominant clonotypes demonstrated high intrinsic antigen avidity, defined strictly as a physical parameter, and were preferentially driven toward terminal differentiation in phenotypically heterogeneous populations. In contrast, subdominant clonotypes were characterized by lower intrinsic avidities and proportionately greater dependency on the pMHCI–CD8 interaction for antigen uptake and functional sensitivity. These findings provide evidence that interclonal competition for antigen operates in human T cell populations, while preferential CD8 coreceptor compensation mitigates this process to maintain clonotypic diversity. Vaccine strategies that reconstruct these biological processes could generate T cell populations that mediate optimal delivery of antiviral effector function.
Skip Nav Destination
Article navigation
21 November 2005
Article Contents
Article|
November 14 2005
Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses
David A. Price,
David A. Price
1Human Immunology Section, Vaccine Research Center
Search for other works by this author on:
Jason M. Brenchley,
Jason M. Brenchley
1Human Immunology Section, Vaccine Research Center
Search for other works by this author on:
Laura E. Ruff,
Laura E. Ruff
1Human Immunology Section, Vaccine Research Center
Search for other works by this author on:
Michael R. Betts,
Michael R. Betts
2Immunology Laboratory, Vaccine Research Center
Search for other works by this author on:
Brenna J. Hill,
Brenna J. Hill
1Human Immunology Section, Vaccine Research Center
Search for other works by this author on:
Mario Roederer,
Mario Roederer
3Immunotechnology Section, Vaccine Research Center
Search for other works by this author on:
Richard A. Koup,
Richard A. Koup
2Immunology Laboratory, Vaccine Research Center
Search for other works by this author on:
Steven A. Migueles,
Steven A. Migueles
4Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Emma Gostick,
Emma Gostick
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Search for other works by this author on:
Linda Wooldridge,
Linda Wooldridge
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Search for other works by this author on:
Andrew K. Sewell,
Andrew K. Sewell
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Search for other works by this author on:
Mark Connors,
Mark Connors
4Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Daniel C. Douek
Daniel C. Douek
1Human Immunology Section, Vaccine Research Center
Search for other works by this author on:
David A. Price
1Human Immunology Section, Vaccine Research Center
Jason M. Brenchley
1Human Immunology Section, Vaccine Research Center
Laura E. Ruff
1Human Immunology Section, Vaccine Research Center
Michael R. Betts
2Immunology Laboratory, Vaccine Research Center
Brenna J. Hill
1Human Immunology Section, Vaccine Research Center
Mario Roederer
3Immunotechnology Section, Vaccine Research Center
Richard A. Koup
2Immunology Laboratory, Vaccine Research Center
Steven A. Migueles
4Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Emma Gostick
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Linda Wooldridge
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Andrew K. Sewell
5Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, England, UK
Mark Connors
4Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Daniel C. Douek
1Human Immunology Section, Vaccine Research Center
CORRESPONDENCE David A. Price: [email protected] OR Daniel C. Douek: [email protected]
Abbreviations used: pMHC, peptide-MHC; pMHCI, pMHC class I.
Received:
July 07 2005
Accepted:
September 19 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (10): 1349–1361.
Article history
Received:
July 07 2005
Accepted:
September 19 2005
Citation
David A. Price, Jason M. Brenchley, Laura E. Ruff, Michael R. Betts, Brenna J. Hill, Mario Roederer, Richard A. Koup, Steven A. Migueles, Emma Gostick, Linda Wooldridge, Andrew K. Sewell, Mark Connors, Daniel C. Douek; Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses . J Exp Med 21 November 2005; 202 (10): 1349–1361. doi: https://doi.org/10.1084/jem.20051357
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement